Acquisition provides I-Mab with upstream rights to CLDN18.2 parental antibody for use in bispecific ... utilized in givastomig has been observed to show a higher affinity to human CLDN18.2 than other ...

On the 27th anniversary of the adoption of the Rome Statute of the International Criminal Court, the Global Initiative Against Impunity reaffirms (…) ...